药物性肝病(drug-induced hepatic disease)简称药肝是指由于药物本身或其代谢产物引起肝脏损害。可以发生在以往没有肝病史的健康者或原来就有严重疾病的病人。
基于78个网页-相关网页
随着新药的大量研发并应用于临床,人类暴露于各类药物的程度大大增加,药物性肝病(drug-induced liver disease,DILD)是临床医生和患者共同面临的重要问题.
基于24个网页-相关网页
...发育、进化和细胞的代谢、衰老以及疾病等众多重要领域 药物性肝病36例临床分析 【关键词】药物性肝病临床分析药物性肝病（DILI）在临床上屡见不鲜，但尚未引起人们和临床医师足够和广泛的重视。随着新药的不断出现及广泛应用，药物性肝病的发病率也相应增加。
基于14个网页-相关网页
老年人药物性肝病 senile drug-induced hepatic disease
中药引起的药物性肝病 drug-induced liver disease ; DILD
急性药物性肝病 Acute drug inducing liver diseases
生药物性肝病 drug-induced liver disease ; DILD
药物性肝病损害 drug inuced liver injury ; DILI
背景药物性肝病 drug induced liver disease ; DILD
即药物性肝病 drug induced liver disease ; DILD
高于急性药物性肝病 acute drug induced liver disease ; ADILD
中药惹起的药物性肝病 drug-induced liver diseottom ; drug-induced liver diseautomotive service engineers ; drug-induced liver diseonese
Objective: To prevent and enhance the understanding ofdrug hepatitis by analyzing the etiology、clinical features、therapeuticefficacy、turnover of 202 cases with drug-induced liver disease.
目的回顾性分析202例药物性肝病患者的病因和临床表现、治疗效果、及其转归、以提高对药物性肝病的认识和防治水平。
参考来源 - 202例药物性肝病的临床分析·2,447,543篇论文数据，部分数据来源于NoteExpress
结论腺苷蛋氨酸治疗药物性肝病具有较好的疗效。
Conclusion Adenosylmethionine can exert significant therapeutic effect on drug induced liver diseases.
随着药物种类的增多，药物性肝病的发病率亦增加。
Incidence of hepatic disease caused by drugs is increasing since drug species are more.
此文主要就药物性肝病的诊断与治疗进展作一综述。
Here we review the progress of diagnosis and treatment of DILD for reference.
应用推荐